Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: An update

British Journal of Dermatology

Volumn 174, Issue 4, 2016, Pages 753-762

  Blanco, I ^a   Lipsker, D ^b   Lara, B ^c   Janciauskiene, S ^d  

^a Board of Directors of the Alpha 1 Antitrypsin Deficiency Spanish Registry Lung Foundation Breathe Spanish Society of Pneumology (SEPAR)   (Spain)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 1 ANTITRYPSIN CONCENTRATE; AZATHIOPRINE; DAPSONE; DOXYCYCLINE; INDOMETACIN; KETOCONAZOLE; PREDNISONE; PROTEIN; PROTEINASE INHIBITOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CLINICAL FEATURE; DERMATOLOGIST; DISEASE ASSOCIATION; DISEASE SEVERITY; EMBASE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIVER TRANSPLANTATION; LUNG EMPHYSEMA; MEDLINE; NEUTROPHILIA; NEUTROPHILIC PANNICULITIS; PANNICULITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SKIN BIOPSY; SKIN DEFECT; SYSTEMATIC REVIEW; TISSUE SECTION; TREATMENT OUTCOME; ADOLESCENT; ADULT; COMPLICATION; FEMALE; MALE; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PANNICULITIS; YOUNG ADULT;

EID: 84971657318     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14309     Document Type: Review

References (89)

1. de Serres F, Blanco I,. Role of alpha-1 antitrypsin in human health and disease. J Intern Med 2014; 276: 311-35.
2. Lomas DA, Evans DL, Finch JT, Carrell RW,. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992; 357: 605-7.
3. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society Statement: standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168: 818-900.
4. Stoller JK, Lacbawan FL, Aboussouan LS,; GeneReviews. Alpha-1 antitrypsin deficiency. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1519/ (last accessed 1 December 2015).
5. Janciauskiene SM, Bals R, Koczulla R, et al,. The discovery of α1-antitrypsin and its role in health and disease. Respir Med 2011; 105: 1129-39.
6. Pérez-Holanda S, Blanco I, Menéndez M, Rodrigo L,. Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls. BMC Cancer 2014; 14: 355.
7. Laurell CB, Eriksson S,. The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15: 132-40.
8. Laurell CB, Eriksson S,. The serum alpha-l-antitrypsin in families with hypo-alpha-l-antitrypsinemia. Clin Chim Acta 1965; 11: 395-8.
9. Janciauskiene S,. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys Acta 2001; 1535: 221-35.
10. Bergin DA, Hurley K, McElvaney NG, Reeves EP,. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Arch Immunol Ther Exp (Warsz) 2012; 60: 81-97.
11. Sinden NJ, Baker MJ, Smith DJ, et al,. α-1-antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2015; 308: L179-90.
12. Jonigk D, Al-Omari M, Maegel L, et al,. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase. Proc Natl Acad Sci U S A 2013; 110: 15007-12.
13. EC. Expanding the clinical indications for a1-antitrypsin therapy. Mol Med 2012; 18: 957-70.
14. Bergin DA, Reeves EP, Meleady P,. α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin Invest 2010; 120: 4236-50.
15. Al-Omari M, Korenbaum E, Ballmaier M, et al,. Acute-phase protein α1-antitrypsin inhibits neutrophil calpain I and induces random migration. Mol Med 2011; 17: 865-74.
16. Petrache I, Fijalkowska I, Medler TR, et al,. α-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 2006; 169: 1155-66.
17. 1-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α. Am J Respir Cell Mol Biol 2013; 49: 143-50.
18. Lockett AD, Petrusca DN, Justice MJ, et al,. Scavenger receptor class B, type I mediated uptake of A1AT by pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 2015; 309: L425-34.
19. Subramaniyam D, Virtala R, Pawłowski K, et al,. TNF-α-induced self-expression in human lung endothelial cells is inhibited by native and oxidized α1-antitrypsin. Int J Biochem Cell Biol 2008; 40: 258-71.
20. Dabbagh K, Laurent GJ, Shock A, et al,. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J Cell Physiol 2001; 186: 73-81.
21. Stockley RA, Bayley DL, Unsal I, Dowson LJ,. The effect of augmentation therapy on bronchial inflammation in α1-antitrypsin deficiency. Am J Respir Crit Care Med 2002; 165: 1494-8.
22. Baraldo S, Turato G, Lunardi F, et al,. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm. Am J Respir Crit Care Med 2015; 191: 402-9.
23. Koulmanda M, Bhasin M, Hoffman L, et al,. Curative and beta cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci U S A 2008; 105: 16242-7.
24. Shahaf G, Moser H, Ozeri E, et al,. α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection. Mol Med 2011; 17: 1000-11.
25. Bellacen K, Kalay N, Ozeri E, et al,. Revascularization of pancreatic islet allografts is enhanced by α-1-antitrypsin under anti-inflammatory conditions. Cell Transplant 2013; 22: 2119-33.
26. Yang L, Liao YT, Yang XF, et al,. Immune protective effect of human α-1-antitrypsin gene during β cell transplantation in diabetic mice. Immunol Res 2015; 62: 71-80.
27. Marcondes AM, Xiang L, Tabellini L, et al,. Inhibition of IL-32 activation by α-1 anti-trypsin reduces alloreactivity and increases survival in an allogeneic murine marrow transplantation model. Blood 2011; 118: 5031-9.
28. Tawara I, Sun Y, Lewis EC, et al,. Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A 2012; 109: 564-9.
29. Grimstein C, Choi YK, Wasserfall CH, et al,. Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model. J Transl Med 2011; 9: 21.
30. Toldo S, Seropian IM, Mezzaroma E, et al,. Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 2011; 51: 244-51.
31. Jedicke N, Struever N, Aggrawal N, et al,. α-1-antitrypsin inhibits acute liver failure in mice. Hepatology 2014; 59: 2299-308.
32. Libert C, Van Molle W, Brouckaert P, Fiers W,. α1-Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 1996; 157: 5126-9.
33. Dhami R, Gilks B, Xie C, et al,. Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by α1-antitrypsin. Am J Respir Cell Mol Biol 2000; 22: 244-52.
34. Churg A, Dai J, Zay K, et al,. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest 2001; 81: 1119-31.
35. Blanco I, Lara B, de Serres F,. Efficacy of α1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis 2011; 6: 14.
36. Shapiro L, Pott GB, Ralston AH,. Alpha-1-antitrypsin inhibits human immunodeficiency virus type-1. FASEB J 2001; 15: 115-22.
37. Bryan CL, Beard KS, Pott GB, et al,. HIV infection is associated with reduced serum alpha-1-antitrypsin concentrations. Clin Invest Med 2010; 33: E384-9.
38. Sandström CS, Ohlsson B, Melander O, et al,. An association between type 2 diabetes and alpha-antitrypsin deficiency. Diabet Med 2008; 25: 1370-3.
39. Pott GB, Chan ED, Dinarello CA, Shapiro L,. Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol 2009; 85: 886-95.
40. Parkes Weber F,. A case of relapsing non-suppurative nodular panniculitis, showing phagocytosis of subcutaneous fat-cells by macrophages. Br J Dermatol Syphilis 1925; 37: 301-11.
41. Christian HA,. Relapsing febrile nodular nonsuppurative panniculitis. Arch Intern Med 1928; 42: 338-51.
42. Warter J, Storck D, Grosshans E, et al,. Weber-Christian syndrome associated with an alpha-1-antitrypsin deficiency. Familial investigation. Ann Med Interne (Paris) 1972; 123: 877-82. (in French).
43. Grosshans E, Warter J, Storck D,. A propos d'une panniculite liquéfiante: les manifestations cutanées del déficits en alpha-I-antitrypsine. Bull Soc Fr Dermatol Syphiligr 1973; 80: 244-7.
44. Rubinstein HM, Jaffer AM, Kudrna JC, et al,. Alpha1-antitrypsin deficiency with severe panniculitis. Report of two cases. Ann Intern Med 1977; 86: 742-4.
45. Guilmot JL, Lamisse F, Choutel P,. Maladie de Weber-Christian associeé a un deficit en alpha-1-antitrypsine. Presse Med 1980; 9: 886.
46. Balk E, Bronsveld W, Van der Deyl JA, et al,. Alpha 1-antitrypsin deficiency with vascular leakage syndrome and panniculitis. Neth J Med 1982; 25: 138-41.
47. Clark P, Breit SN, Dawkins RL, Penny R,. Genetic study of a family with two members with Weber Christian disease (panniculitis) and alpha 1 antitrypsin deficiency. Am J Med Genet 1982; 13: 57-62.
48. Pottage JC Jr, Trenholme GM, Aronson IK, Harris AA,. Panniculitis associated with histoplasmosis and alpha 1-antitrypsin deficiency. Am J Med 1983; 75: 150-3.
49. Bleumink E, Klokke AH,. Protease-inhibitor deficiencies in a patient with Weber-Christian panniculitis. Arch Dermatol 1984; 120: 936-40.
50. Bleumink E, Klokke AH,. Relationship between Weber-Christian panniculitis and the ZZ phenotype of α1-antitrypsin. Arch Dermatol Res 1985; 277: 328-9.
51. Lonchampt L, Blanc D, Terrase F,. Maladie de Weber-Christian associée a un deficit familial en alfa-I-antitrypsine. Ann Dermatol Venereol 1985; 112: 35-9.
52. Hendrick SJ, Silverman AK, Solomon AR, Headington JT,. Alpha 1-antitrypsin deficiency associated with panniculitis. J Am Acad Dermatol 1988; 18: 684-92.
53. Valverde R, Rosales B, Ortiz-de Frutos FJ, et al,. Alpha-1-antitrypsin deficiency panniculitis. Dermatol Clin 2008; 26: 447-51.
54. Chan MP,. Neutrophilic panniculitis: algorithmic approach to a heterogeneous group of disorders. Arch Pathol Lab Med 2014; 138: 1337-43.
55. Smith KC, Su WPD, Pittelkow MR, Winkelmann RK,. Clinical and pathologic correlation in 96 patients with panniculitis, including 15 patients with deficient levels of alpha 1-antitrypsin. J Am Acad Dermatol 1989; 21: 1192-6.
56. Geller JD, Su WPD,. A subtle clue to the histopathologic diagnosis of early alpha 1-antitrypsin deficiency panniculitis. J Am Acad Dermatol 1994; 31: 241-5.
57. 1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy. Dermatology 2009; 218: 370-5.
58. Wewers MD, Casolaro MA, Sellers SE, et al,. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987; 316: 1055-62.
59. Smith KC, Pittelkow MR, Su WP,. Panniculitis associated with severe alpha 1-antitrypsin deficiency. Treatment and review of the literature. Arch Dermatol 1987; 123: 1655-61.
60. Edmonds BK, Hodge JA, Rietschel RL,. Alpha 1-antitrypsin deficiency-associated panniculitis: case report and review of the literature. Pediatr Dermatol 1991; 8: 296-9.
61. Parr DG, Stewart DG, Hero I, Stockley RA,. Panniculitis secondary to extravasation of clarithromycin in a patient with α1-antitrypsin deficiency (phenotype PiZ). Br J Dermatol 2003; 149: 410-13.
62. Ortiz PG, Skov BG, Benfeldt E,. Alpha1-antitrypsin deficiency-associated panniculitis: case report and review of treatment options. J Eur Acad Dermatol Venereol 2005; 19: 487-90.
63. Laureano A, Carvalho R, Chaveiro A, Cardoso J,. Alpha-1-antitrypsin deficiency-associated panniculitis: a case report. Dermatol Online J 2014; 20: 21245.
64. 1-antitrypsin deficiency: panniculitis absent on biopsy. Cutis 2014; 93: 303-6.
65. White JW Jr, Winkelmann RK,. Weber-Christian panniculitis: a review of 30 cases with this diagnosis. J Am Acad Dermatol 1998; 39: 56-62.
66. Pinto AR, Maciel LS, Carneiro F, et al,. Systemic nodular panniculitis in a patient with α-1 antitrypsin deficiency (PiSS phenotype). Clin Exp Dermatol 1993; 18: 154-5.
67. Gaillard MC, Bothwell J, Dreyer L,. A case of systemic nodular panniculitis associated with M1 (Val213) Z phenotype of α1-protease inhibitor. Int J Dermatol 1997; 36: 278-80.
68. Loche F, Tremeau-Martinage C, Laplanche G, et al,. Panniculitis revealing qualitative α1 antitrypsine deficiency (MS variant). Eur J Dermatol 1999; 9: 565-7.
69. Albes B, Bayle-Lebey P, Bazex J, Lamant L,. Panniculitis revealing α-1 antitrypsin deficiency. Report of 3 cases. Ann Med Interne (Paris) 2001; 152: 502-6. (in French).
70. Chng WJ, Henderson CA,. Suppurative panniculitis associated with α1-antitrypsin deficiency (PiSZ phenotype) treated with doxycycline. Br J Dermatol 2001; 144: 1282-3.
71. Geraminejad P, DeBloom JR, Walling HW, et al,. Alpha-1-antitrypsin associated panniculitis: the MS variant. J Am Acad Dermatol 2004; 51: 645-55.
72. Furey NL, Golden RS, Potts SR,. Treatment of alpha-1-antitrypsin deficiency, massive edema, and panniculitis with α-1 protease inhibitor. Ann Intern Med 1996; 125: 699.
73. O'Riordan K, Blei A, Rao MS, Abecassis M,. α1-antitrypsin deficiency-associated panniculitis: resolution with intravenous α1-antitrypsin administration and liver transplantation. Transplantation 1997; 63: 480-2.
74. Chowdhury MM, Williams EJ, Morris JS, et al,. Severe panniculitis caused by homozygous ZZ α1-antitrypsin deficiency treated successfully with human purified enzyme (Prolastin). Br J Dermatol 2002; 147: 1258-61.
75. Kjus T, Lützow-Holm C, Christensen OB,. Treatment of panniculitis associated with α-1-antitrypsin deficiency with α-1-protease inhibitor. Acta Derm Venereol 2003; 83: 462-3.
76. Fernández-Torres R, García-Silva J, Robles O, et al,. Alfa-1-antitrypsin deficiency panniculitis acquired after liver transplant and successfully treated with retransplant. J Am Acad Dermatol 2009; 60: 715-16.
77. Lipsker D, Perrigouard C, Foubert A, Cribier B,. Anakinra for difficult-to-treat neutrophilic panniculitis: IL-1 blockade as a promising treatment option for neutrophil-mediated inflammatory skin disease. Dermatology 2010; 220: 264-7.
78. Al-Niaimi F, Lyon C,. Severe ulcerative panniculitis caused by α1-antitrypsin deficiency: remission induced and maintained with intravenous α1-antitrypsin. J Am Acad Dermatol 2011; 65: 227-9.
79. Olson JM, Moore EC, Valasek MA, et al,. Panniculitis in alpha-1 antitrypsin deficiency treated with enzyme replacement. J Am Acad Dermatol 2012; 66: e139-41.
80. Elsensohn AN, Curtis JA, Secrest AM, et al,. Alpha-1-antitrypsin deficiency panniculitis presenting with severe anasarca, pulmonary embolus, and hypogammaglobulinaemia. Br J Dermatol 2015; 173: 289-91.
81. Cathomas M, Schüller A, Candinas D, Inglin R,. Severe postoperative wound healing disturbance in a patient with α-1-antitrypsin deficiency: the impact of augmentation therapy. Int Wound J 2015; 12: 601-4.
82. Eckhard M, Kröll KP, Karrasch T, et al,. Panniculitis of the thigh and lung emphysema in a 54-year-old patient. Der Internist 2015; 56: 696-701. (in German).
83. McElvaney NG, Stoller JK, Buist AS, et al,. Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of α1-antitrypsin deficiency. Chest 1997; 111: 394-403.
84. Linares-Barrios M, Conejo-Mir IS, Artola Igarza JL, Navarrete M,. Panniculitis due to α1-antitrypsin deficiency induced by cryosurgery. Br J Dermatol 1998; 138: 552-3.
85. Rajagopal R, Malik AK, Murthy PS, Neog LS,. Alpha-1 antitrypsin deficiency panniculitis. Indian J Dermatol Venereol Leprol 2002; 68: 362-4.
86. Mahadeva R, Atkinson C, Li Z, et al,. Polymers of Z α1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol 2005; 166: 377-86.
87. Hurley K, Lacey N, O'Dwyer CA, et al,. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals. J Immunol 2014; 193: 3978-91.
88. Bergin DA, Reeves EP, Hurley K, et al,. The circulating proteinase inhibitor a-1 antitrypsin regulates neutrophil degranulation and autoimmunity. Sci Transl Med 2014; 6: 217ra1.
89. Stoller JK, Piliang M,. Panniculitis in α-1antitrypsin deficiency: a review. Clin Pulm Med 2008; 15: 113-17.